The abstract is read at the publisher; the summary is JClub's.
Acquired cytomegalovirus in children is biologically active and context-dependent, with strongest evidence of harm in infants born preterm and those living with or exposed to HIV.
- Why it matters: Postnatally acquired CMV is often assumed benign, yet evidence indicates it can shape immune development and health trajectories, creating a need to clarify when it harms versus remains silent.
- What they did: This Review synthesizes evidence on epidemiology, transmission, immune responses, and clinical consequences to assess whether acquired CMV is a driver, neutral bystander, or beneficial immune trainer.
- The result: The balance of harm versus neutrality varies by timing, host immune maturity, maternal health, co-infections, and social/environmental factors, implying targeted prevention and treatment for high-risk groups rather than universal intervention.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.